Search research articles
Contact Us
Filters
Showing results (291-300 of 421) with videos related to
Page
of 43
Sort By:
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society
|
May 17, 2021
Efficacy of clotrimazole for the management of oral candidiasis: A meta-analysis of randomized clinical trials
Thamer A Almangour, Keith S Kaye, Mohammed Alessa, et al.
Infection Control and Hospital Epidemiology
|
May 7, 2014
Strategies to prevent surgical site infections in acute care hospitals: 2014 update
Deverick J Anderson, Kelly Podgorny, Sandra I Berríos-Torres, et al.
Infection Control and Hospital Epidemiology
|
November 8, 2014
Strategies to prevent surgical site infections in acute care hospitals: 2014 update
Deverick J Anderson, Kelly Podgorny, Sandra I Berríos-Torres, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 14, 2024
Lowering the Acquisition of Multidrug-Resistant Organisms (MDROs) With Pulsed-xenon (LAMP) Study: A Cluster-Randomized, Controlled, Double-Blinded, Interventional Crossover Trial
Sorabh Dhar, Chetan Jinadatha, Paul E Kilgore, et al.
Circulation
|
June 25, 2003
Staphylococcus aureus bacteremia after median sternotomy: clinical utility of blood culture results in the identification of postoperative mediastinitis
Vance G Fowler, Keith S Kaye, David L Simel, et al.
The Journal of Antibiotics
|
May 30, 2013
Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10
Jason M Pogue, Dror Marchaim, Odaliz Abreu-Lanfranco, et al.
The Lancet. Infectious Diseases
|
May 14, 2023
Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)
Keith S Kaye, Andrew F Shorr, Richard G Wunderink, et al.
Frontiers in Pharmacology
|
October 22, 2019
Synergistic Combination of Polymyxin B and Enrofloxacin Induced Metabolic Perturbations in Extensive Drug-Resistant <i>Pseudomonas aeruginosa</i>
Yu-Wei Lin, Mei-Ling Han, Jinxin Zhao, et al.
The Lancet. Infectious Diseases
|
December 3, 2014
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
Roger L Nation, Jian Li, Otto Cars, et al.
Antimicrobial Agents and Chemotherapy
|
October 9, 2013
Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes
Teena Chopra, Dror Marchaim, Reda A Awali, et al.
Page
of 43
Search research articles
Search
Showing results (291-300 of 421) with videos related to
Sort By:
Page
of 43
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society
|
May 17, 2021
Efficacy of clotrimazole for the management of oral candidiasis: A meta-analysis of randomized clinical trials
Thamer A Almangour, Keith S Kaye, Mohammed Alessa, et al.
Infection Control and Hospital Epidemiology
|
May 7, 2014
Strategies to prevent surgical site infections in acute care hospitals: 2014 update
Deverick J Anderson, Kelly Podgorny, Sandra I Berríos-Torres, et al.
Infection Control and Hospital Epidemiology
|
November 8, 2014
Strategies to prevent surgical site infections in acute care hospitals: 2014 update
Deverick J Anderson, Kelly Podgorny, Sandra I Berríos-Torres, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 14, 2024
Lowering the Acquisition of Multidrug-Resistant Organisms (MDROs) With Pulsed-xenon (LAMP) Study: A Cluster-Randomized, Controlled, Double-Blinded, Interventional Crossover Trial
Sorabh Dhar, Chetan Jinadatha, Paul E Kilgore, et al.
Circulation
|
June 25, 2003
Staphylococcus aureus bacteremia after median sternotomy: clinical utility of blood culture results in the identification of postoperative mediastinitis
Vance G Fowler, Keith S Kaye, David L Simel, et al.
The Journal of Antibiotics
|
May 30, 2013
Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10
Jason M Pogue, Dror Marchaim, Odaliz Abreu-Lanfranco, et al.
The Lancet. Infectious Diseases
|
May 14, 2023
Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)
Keith S Kaye, Andrew F Shorr, Richard G Wunderink, et al.
Frontiers in Pharmacology
|
October 22, 2019
Synergistic Combination of Polymyxin B and Enrofloxacin Induced Metabolic Perturbations in Extensive Drug-Resistant <i>Pseudomonas aeruginosa</i>
Yu-Wei Lin, Mei-Ling Han, Jinxin Zhao, et al.
The Lancet. Infectious Diseases
|
December 3, 2014
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
Roger L Nation, Jian Li, Otto Cars, et al.
Antimicrobial Agents and Chemotherapy
|
October 9, 2013
Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes
Teena Chopra, Dror Marchaim, Reda A Awali, et al.
Page
of 43